Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3083)	5/27/1999 6:52:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 10280

Peter and thread: Can you give a newbie a primer on Sepracor's ICE, versus what other companies do along the lines of generating single isomer drugs. How does Sepracor have a lock on this stuff--was it just a mad rush to patent the molecules, and quick establishment of a good pipeline? I had a target of $80 to buy this one as it slipped back into double digits. That it went down so low is surprising to me, I guess it has been labeled a momentum stock, and so everybody got out when the momo drained out. I'd love to get myself a hundred shares if any of my nanocaps pay off in the next couple of months. I suppose by the time one does pay off, SEPR will be back around $100. Hey, all those lurking who have sold SEPR, with your cash please buy NTII--then when it hits $2 I can sell a third of my position and get my first 100 shares of Sepracor. Thank you for your support;-)